Neuphoria Therapeutics In...

NASDAQ: NEUP · Real-Time Price · USD
8.02
0.07 (0.88%)
At close: Aug 14, 2025, 3:59 PM
7.99
-0.37%
Pre-market: Aug 15, 2025, 07:00 AM EDT

Neuphoria Therapeutics Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Revenue
n/a n/a 6.06M 928.07K
Cost of Revenue
n/a n/a 16M 5.76M
Gross Profit
n/a n/a -9.94M -4.83M
Operating Income
-17.89M -21.56M -14.68M -8.96M
Interest Income
220.1K 323.16K 6.79K 4.29K
Pretax Income
-15.58M -21.52M -15.1M -6.68M
Net Income
-15.49M -21.38M -14.97M -6.53M
Selling & General & Admin
8.47M 8.91M 5.27M 4.24M
Research & Development
9.42M 13.07M 11.01M 4.33M
Other Expenses
n/a -422.74K 7.38M 386.74K
Operating Expenses
17.89M 21.56M 23.66M 8.96M
Interest Expense
n/a 14.08K 18.48K 1.08M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
17.89M 21.56M 14.86M 8.96M
Income Tax Expense
-87.32K -139.17K -131.95K -140.82K
Shares Outstanding (Basic)
149.8M 122.39M 112.78M 65M
Shares Outstanding (Diluted)
149.8M 122.39M 112.78M 65M
EPS (Basic)
-0.1 -0.17 -0.13 -0.1
EPS (Diluted)
-0.1 -0.17 -0.13 -0.1
EBITDA
-17.13M -20.9M -14.32M -4.51M
EBIT
-17.8M -21.56M -15.08M -5.79M
Depreciation & Amortization
662.99K 663.19K 763.17K 1.28M